Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 29 January 1999

Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer

  • H M McDaid1,
  • M T Cairns1,
  • R J Atkinson1,
  • S McAleer1,
  • D P Harkin1,
  • P Gilmore1 &
  • …
  • P G Johnston1 

British Journal of Cancer volume 79, pages 933–939 (1999)Cite this article

  • 736 Accesses

  • 52 Citations

  • Metrics details

This article has been updated

Summary

The primary element in the cAMP signal transduction pathway is the cAMP-dependent protein kinase (PKA). Expression of the RIα subunit of type I PKA is elevated in a variety of human tumours and cancer cell lines. The purpose of this study was to assess the prognostic importance of RIα expression in patients with ovarian cancer. We have evaluated the expression of RIα in a panel of human ovarian tumours (n= 40) and five human ovarian cancer cell lines using quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The human ovarian cell lines OAW42 and OTN14 express high endogenous levels of RIα mRNA and protein (at significantly higher mRNA levels than high tissue expressors, P< 0.05). The ovarian cell line A2780 expresses low endogenous levels of RIα mRNA and protein (also at higher mRNA levels than low tissue expressors, P< 0.05). Quantitative RT-PCR revealed no significant difference in RIα mRNA expression between different ovarian histological subtypes in this study. No associations were found between RIα mRNA expression and differentiation state. RIα mRNA expression was significantly associated with tumour stage (P= 0.0036), and this remained significant in univariate analysis (P= 0.0002). A trend emerged between RIα mRNA expression levels and overall survival in univariate analysis (P= 0.051), however, by multivariate analysis, stage remained the major determinant of overall survival (P= 0.0001). This study indicates that in ovarian epithelial tumours high RIα mRNA expression is associated with advanced stage disease. RIα expression may be of predictive value in ovarian cancer and may be associated with dysfunctional signalling pathways in this cancer type.

Similar content being viewed by others

Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer

Article 19 November 2021

Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment

Article Open access 01 October 2022

Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts

Article Open access 11 November 2022

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Beebe, S. J. (1994). The cAMP-dependent protein kinases and cAMP signal transduction. Semin Cancer Biol 5: 285–294.

    CAS  PubMed  Google Scholar 

  • Bradford, M. M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248–254.

    Article  CAS  Google Scholar 

  • Cho-Chung, Y. S. (1990). Role of cAMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 50: 7093–7100.

    CAS  PubMed  Google Scholar 

  • Cho-Chung, Y. S. (1993). Differentiation therapy of cancer targeting the RIα regulatory subunit of cAMP-dependent protein kinase. Int J Oncol 3: 141–148.

    CAS  Google Scholar 

  • Land, J. A. (1987). Ovulation, ovulation induction and ovarian carcinoma. Baillières Clin Obstet Gynaecol 43: 455–470.

    Google Scholar 

  • Langdon, S. P., Lawrie, S. S. & Hay, F. G. (1988). Characterisation and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res 48: 6166–6172.

    CAS  PubMed  Google Scholar 

  • Leonard, M. W., Lim, K-C & Engel, J. D. (1993). Expression of the chicken GATA factor family during early erythoid development and differentiation. Development 119: 519–531.

    CAS  PubMed  Google Scholar 

  • McDaid, H., Cairns, M. T., Church, S., White, P. & Johnston, P. G. (1997). Response to 8-Cl-cAMP in a panel of human cancer cell lines is dependent on intrinsic RIα expression levels. Proc Am Assoc Cancer Res 38: abstract 2823

  • Miller, W. R., Hulme, M. J., McCallum, J., Cameron, D. A., Dixon, J. M. & Bartlett, J. M. S. (1996). Tumour RIα mRNA and response to tamoxifen in patients with breast cancer. Proc Am Assoc Cancer Res 37: abstact 1627

  • Nesterova, M. & Cho-Chung, Y. S. (1995). A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nature Med 1: 528–533.

    Article  CAS  Google Scholar 

  • NIH Consensus Statement (1994). Ovarian cancer: screening, treatment and follow-up. In NIH Consens Statment 12: 1–30.

  • Parker, S. L., Tong, T., Bolden, S. & Wingo, P. A. (1996). Cancer statistics, 1996. CA Cancer Clin 46: 5–27.

    Article  CAS  Google Scholar 

  • Reimann, K. V., Walsh, D. A. & Krebs, E. G. (1971). Purification and properties of rabbit skeletal muscle adenosine 3′,5′-monophosphate-dependent protein kinases. J Biol Chem 246: 1986

    CAS  PubMed  Google Scholar 

  • Simpson, B. J. B., Ramage, A. D., Hulme, M. J., Burns, D. J., Katsaros, D., Langdon, S. P. & Miller, W. R. (1996). Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features. Clin Cancer Res 2: 201–206.

    CAS  PubMed  Google Scholar 

  • Tortora, G., Ciardiello, F., Pepe, S., Tagliaferri, P., Ruggiero, A., Bianco, C., Guarrasi, R., Miki, K. & Raffaele Bianco, A. (1995). Phase I clinical study with 8-Cl-cAMP and evaluation of immunological effects in cancer patients. Clin Cancer Res 51: 1600–1605.

    Google Scholar 

  • Van Niekerk, C. C., Poels, L. G., Jap, P. H., Smeets, D. F., Thomas, C. M., Ramaekers, F. C. & Voous, G. P. (1988). Characterisation of a human ovarian carcinoma cell line, OTN14 derived from a mucinous cystadenocarcinoma. Int J Cancer 42: 104–111.

    Article  CAS  Google Scholar 

  • Walsh, D. A., Perkins, J. P. & Krebs, E. G. (1968). An adenosine 3′,5′-monophosphate-dependent protein kinase from rabbit skeletal muscle. J Biol Chem 243: 3763–3765.

    CAS  PubMed  Google Scholar 

  • Whelan, S. L. & Ferlay, J. (1992). Cancer incidence in five continents. Age-specific and standardized incidence rates. IARC Sci Publ 120: 178–861.

    Google Scholar 

  • Wilson, A. P. (1984). Characterisation of a cell line derived from the ascites of a patient with papillary serous cystadenoma of the ovary. J Natl Cancer Inst 72: 513–521.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, The Queen’s University of Belfast, University Floor, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK

    H M McDaid, M T Cairns, R J Atkinson, S McAleer, D P Harkin, P Gilmore & P G Johnston

Authors
  1. H M McDaid
    View author publications

    Search author on:PubMed Google Scholar

  2. M T Cairns
    View author publications

    Search author on:PubMed Google Scholar

  3. R J Atkinson
    View author publications

    Search author on:PubMed Google Scholar

  4. S McAleer
    View author publications

    Search author on:PubMed Google Scholar

  5. D P Harkin
    View author publications

    Search author on:PubMed Google Scholar

  6. P Gilmore
    View author publications

    Search author on:PubMed Google Scholar

  7. P G Johnston
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

McDaid, H., Cairns, M., Atkinson, R. et al. Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. Br J Cancer 79, 933–939 (1999). https://doi.org/10.1038/sj.bjc.6690149

Download citation

  • Received: 30 December 1997

  • Revised: 22 May 1998

  • Accepted: 02 June 1998

  • Published: 29 January 1999

  • Issue date: 01 February 1999

  • DOI: https://doi.org/10.1038/sj.bjc.6690149

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • type I-cAMP-dependent protein kinase
  • reverse transcription polymerase chain reaction
  • ovarian cancer
  • cAMP

This article is cited by

  • Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes

    • Fausto J. Rodriguez
    • Constantine A. Stratakis
    • D. Gareth Evans

    Acta Neuropathologica (2012)

  • Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform

    • Øystein Stakkestad
    • Anja CV Larsen
    • Bjørn S Skålhegg

    BMC Biochemistry (2011)

  • Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model

    • Virginie Follin-Arbelet
    • Peter O Hofgaard
    • Heidi K Blomhoff

    BMC Cancer (2011)

  • Alternative promoter usage and differential expression of multiple transcripts of mouse Prkar1a gene

    • Abdul Rouf Banday
    • Shafquat Azim
    • Mohammad Tabish

    Molecular and Cellular Biochemistry (2011)

  • Inherited disposition to cardiac myxoma development

    • David Wilkes
    • Konstantinos Charitakis
    • Craig T. Basson

    Nature Reviews Cancer (2006)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited